According to Precedence Research, the global radiopharmaceutical CDMO market size is predicted to surpass around USD 8.50 ...
Increase in prevalence of chronic diseases, surge in the adoption of strategies by key players, and rise in R&D activities in the radiopharmaceuticals sector drive the growth of the global ...
The global Radiopharmaceuticals market revenue was USD 6761 Million in 2022 and is forecast to a readjusted size of USD 11660 Million by 2029 with a CAGR of 8.0% during the forecast period (2023-2029) ...
Radiopharmaceuticals Market Experiences Growth Due to Surging Incidences of Chronic Diseases, the report runs an in-depth analysis of market trends, key players, Share, Trend, growth analysis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results